1H-Benzimidazole-2-carboxylic acid | CAS:2849-93-6

We serve 1H-Benzimidazole-2-carboxylic acid CAS:2849-93-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1H-Benzimidazole-2-carboxylic acid

CAS No: 2849-93-6
Product Name: 1H-Benzimidazole-2-carboxylic acid
Other Name:
1H-Benzimidazole-2-carboxylic acid
2-Benzimidazolecarboxylic Acid
 
Density: 1.5±0.1 g/cm3
Boiling Point: 444.0±28.0 °C at 760 mmHg
Melting Point: 169ºC
Molecular Formula: C8H6N2O2
Molecular Weight: 162.145
Flash Point: 222.3±24.0 °C
Exact Mass: 162.042923
PSA: 65.98000
LogP: 1.06
Vapour Pressure: 0.0±1.1 mmHg at 25°C
Index of Refraction: 1.743
Storage condition: 2-8°C
 
Specification
Appearance: White solid
Assay: ≥99.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 1H-Benzimidazole-2-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Benzimidazolecarboxylic Acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Benzimidazolecarboxylic Acid Use and application,1H-Benzimidazole-2-carboxylic acid technical grade,usp/ep/jp grade.


Related News: Chinese nationals coming from China and connecting through another foreign airport will be denied travel. Those with pre-clearance are exempted.4-Bromo-9H-carbazole manufacturer ICIG has agreed to offer employment to the unit’s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland.1,1-Cyclohexanediacetic acid supplier Here’s what we can tell you so far:Propyl isocyanate vendor In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry”, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. .The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.